In this video, Dr. Nicola Normanno (National Cancer Institute Pascale Foundation, Naples Italy) explains how the institute became a reference center for NGS and precision oncology in southern Italy. He describes the research on homologous recombination deficiency (HRD) and which assay characteristics labs should consider when internalizing HRD testing for ovarian cancer.

#HRD #CGP #precisionmedicine #oncology #diagnostics #BRCA #cancer #illumina

Subscribe to the Illumina video channel http://www.youtube.com/subscription_c...

A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.

View customer spotlight videos
   • Illumina Customer Testimonials  

View Illumina webinars
   • Webinars  

View Illumina support videos
   • Illumina Support  

Facebook:   / illuminainc  
LinkedIn:   / illumina  
Instagram:   / illuminainc  
Twitter:   / illumina